Terms: = Uterine cancer AND PLCG1, PLC1, 5335, ENSG00000124181, PLC-II, Plcg1, PLCgamma1, PLC148
7 results:
1. E7050 Suppresses the Growth of Multidrug-Resistant Human uterine Sarcoma by Inhibiting Angiogenesis via Targeting of VEGFR2-Mediated Signaling Pathways.
Huang TT; Chen CM; Lin SS; Lan YW; Cheng HC; Choo KB; Wang CC; Huang TH; Chong KY
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298555
[TBL] [Abstract] [Full Text] [Related]
2. Single-port access (SPA) laparoscopic myomectomy with uterine artery ligation via a retroperitoneal approach is feasible in women with large uterine leiomyoma.
Noh JJ; Kim J; Paik ES; Kang JH; Jeong SY; Choi CH; Lee YY; Lee JW; Kim BG; Bae DS; Kim TJ
Taiwan J Obstet Gynecol; 2021 Jul; 60(4):752-757. PubMed ID: 34247819
[TBL] [Abstract] [Full Text] [Related]
3. MicroRNA‑126‑3p suppresses HeLa cell proliferation, migration and invasion, and increases apoptosis via the PI3K/PDK1/AKT pathway.
Ichikawa R; Kawasaki R; Iwata A; Otani S; Nishio E; Nomura H; Fujii T
Oncol Rep; 2020 Apr; 43(4):1300-1308. PubMed ID: 32323808
[TBL] [Abstract] [Full Text] [Related]
4. Mapping Transient Protein Interactions at the Nanoscale in Living Mammalian Cells.
De Keersmaecker H; Camacho R; Rantasa DM; Fron E; Uji-I H; Mizuno H; Rocha S
ACS Nano; 2018 Oct; 12(10):9842-9854. PubMed ID: 30192513
[TBL] [Abstract] [Full Text] [Related]
5. Alteration in PI3K/mTOR, MAPK pathways and Her2 expression/amplification is more frequent in uterine serous carcinoma than ovarian serous carcinoma.
Mahdi H; Xiu J; Reddy SK; DeBernardo R
J Surg Oncol; 2015 Aug; 112(2):188-94. PubMed ID: 26250968
[TBL] [Abstract] [Full Text] [Related]
6. [Proteinchip-flight mass spectrometry for screening differentially expressed proteins in the serum of cervical cancer patients].
Cai SN; Liu GB; Guo XH; Chen JG; Zhang J; Wu YL; Liang WJ; Luo RC
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Jan; 29(1):32-5. PubMed ID: 19218106
[TBL] [Abstract] [Full Text] [Related]
7. Diagnostic clinical application of two-color fluorescence in situ hybridization that detects chromosome 1 and 17 alterations to direct touch smear and liquid-based thin-layer cytologic preparations of endometrial cancers.
Susumu N; Aoki D; Noda T; Nagashima Y; Hirao T; Tamada Y; Banno K; Suzuki A; Suzuki N; Tsuda H; Inazawa J; Nozawa S
Int J Gynecol Cancer; 2005; 15(1):70-80. PubMed ID: 15670300
[TBL] [Abstract] [Full Text] [Related]
